Pfizer COVID-19 vaccine on verge of emergency use authorization after panel recommendation

Photo of vaccine bottles
If the FDA acts on its vaccine advisory committee's recommendations, Texas' first doses could be administered as soon as Dec. 14. (Courtesy Adobe Stock)

If the FDA acts on its vaccine advisory committee's recommendations, Texas' first doses could be administered as soon as Dec. 14. (Courtesy Adobe Stock)

An expert panel has advised the U.S. Food and Drug Administration to grant emergency use authorization, or EUA, to the COVID-19 vaccine produced by pharmaceutical company Pfizer and biotechnology firm BioNTech. A majority of the FDA's Vaccines and Related Biological Products Advisory Committee, a 23-person body of scientists, doctors, statisticians and industry professionals, voted Dec. 10 that the benefits of the Pfizer-BioNTech COVID-19 vaccine outweigh its risks for use in individuals age 16 and older "based on the totality of scientific evidence available." Four members voted no, and one abstained.

If the FDA acts in accordance with the committee's recommendation, the Texas Department of State Health Services would have the green light to begin distribution of its first round of 224,000 doses of the vaccine to health care workers across the state as soon as mid-December.

What is EUA?

The FDA sometimes grants EUA to drugs and vaccines that have the potential to diagnose, treat or prevent illness during public health emergencies when there are no existing, formally approved alternatives.

While vaccine manufacturers must still go through an extensive clinical trial process, the FDA's threshold for an EUA is not as strict as its threshold for formal approval of a drug. The FDA is able to revoke the EUA at any time if significant adverse effects are reported or new information about the treatment’s efficacy comes to light. Last summer, for instance, the FDA revoked EUA previously granted for hydroxychloroquine, a malaria drug that was sometimes used to treat COVID-19, after further results indicated it was not an effective treatment for the novel coronavirus.

Given EUA, Pfizer’s clinical trials would continue. The original trial subjects would continue to be monitored for up to two years to study whether there are any lingering effects from the vaccine, as is typical in vaccine trials.

Eventually, Pfizer’s vaccine would likely gain full approval, pending further trial results. One member of the advisory committee said he wanted to see Pfizer’s vaccine move quickly from EUA to approval through a traditional Biologics License Application, given the vaccine’s high exhibited rate of efficacy.

Findings and discussion points

Representatives from Pfizer and the FDA presented findings from Pfizer’s clinical trials that showed an efficacy rate of 95% in controlled conditions. High efficacy rates held steady across trial groups, including those with conditions such as diabetes, obesity or cardiovascular disease.

In guidance released over the summer, the FDA said efficacy of 50% would be a requirement for authorization for any COVID-19 vaccine.

Recorded side effects from the vaccine, a two-dose shot, were typically mild, with the most common side effect being pain and swelling around the injection site. Several committee members encouraged the FDA to issue specific guidance regarding individuals with severe allergies after reports from the United Kingdom, where the vaccine has already been authorized, of two patients with a history of severe allergies experiencing anaphylaxis as a possible reaction to the vaccine.

Health authorities in the U.K. have also cited four instances of Bell’s Palsy symptoms, or partial facial paralysis, following the vaccine, but an FDA representative said there was no evidence these symptoms were caused by the vaccine, and most symptoms resolved themselves, except in one individual who had a previous history of Bell’s Palsy.

These instances were rare and inconclusive, and FDA representative Susan Wollersheim said the vaccine was found to be generally safe.

Experts in Texas have also expressed confidence in the vaccine's safety, including Dr. Terrance Hines, chief medical officer of University Health Services at The University of Texas at Austin.

"We have faith in the vaccine and the science behind it, in its safety and its effectiveness," Hines said Dec. 8 when announcing a plan to begin local administration of the vaccine at UT Austin.

Other vaccines

The committee is set to consider a COVID-19 vaccine produced by Moderna on Dec. 17. The group will similarly consider results from Moderna's clinical trials and make a recommendation to the FDA regarding EUA. If the FDA were to authorize the Pfizer vaccine and the Moderna vaccine, more than one vaccine could be in circulation, including in Texas. Currently, the United States is only contractually assured 100 million doses of Pfizer's vaccine, enough to vaccinate 50 million Americans. Pfizer representatives have said it may not be able to provide more Americans with vaccines until June, once the initial 100 million doses are administered.
By Olivia Aldridge
Olivia is the reporter for Community Impact's Central Austin edition. A graduate of Presbyterian College in upstate South Carolina, Olivia was a reporter and producer at South Carolina Public Radio before joining Community Impact in Austin.


Austin government, nonprofit and business leaders recently participated in a weeks-long summit centered on unsheltered homelessness in the city. (Ben Thompson/Community Impact Newspaper)
Plan to house 3,000 homeless individuals in Austin in the next three years would cost $515 million

The plan Austin City Council members discussed April 20 emerged from a weekslong community-wide summit on homelessness.

Photo of Zilker Park
Travis County establishes Civilian Conservation Corps to tackle climate, environmental projects

The program will create opportunities for residents to work on projects including wildfire prevention, solar energy promotion and park cleanups.

Residents march to the Texas Capitol in protests after the killing of George Floyd in May 2020. (Community Impact Newspaper staff)
Austin leaders react to Derek Chauvin guilty verdict

The former Minneapolis police officer was found guilty of second-degree murder, third-degree murder and manslaughter for the killing of George Floyd in May 2020.

Austin Public Health Director Stephanie Hayden-Howard speaks to reporters March 13 at the Delco Actiity Center in Northeast Austin. Residents can walk up to the Delco Center on April 22 and 23 and receive vaccines without an appointment. (Jack Flagler/Community Impact Newspaper)
Austin Public Health will accept walk-up vaccinations at the Delco Activity Center starting April 22

APH will also leave its registration portal open throughout most of the week.

Early voting for Travis County's May 1 local elections opened April 19. In this file photo, voters line up ahead of the 2020 primary elections at Millennium Youth Entertainment Complex in East Austin. (Jack Flagler/Community Impact Newspaper)
More than 8,000 Travis County voters cast ballots on first day of early voting

Early voting for the county's May 1 election began April 19 and will run through April 27.

The Delco Activity Center in Northeast Austin is one of the locations where residents can receive a COVID-19 vaccine. (Jack Flalger/Community Impact Newspaper)
Austin vaccine updates: Demand slows as state begins marketing push

Appointments are beginning to go unfilled, and local health officials say demand has caught up to supply. All adults in the U.S. are now eligible to be vaccinated.

Blue Corn Harvest Leander is located at 11840 Hero Way W., Bldg. A, Leander. (Taylor Girtman/Community Impact Newspaper)
Blue Corn Harvest opens in Leander; park, pizzeria launches social club and more Central Texas news

Read the latest business and community news from the Central Texas area.

Photo of two performers on an outdoor SXSW stage
South by Southwest sells ownership stake in company to Rolling Stone owner Penske Media Corp.

SXSW leadership called the sale a "lifeline" for the conference and festivals.

Photo of people receiving vaccines in a gym
Austin Public Health lengthens windows for vaccine appointment signups

Residents age 18 and up can now sign up for appointments with APH any time from Saturday to Tuesday morning.

Austin Anthem watch party
Crowds of fans converge on North Austin to watch inaugural Austin FC game

Breweries around Q2 Stadium in North Austin brought in large outdoor screens and new employees to host fans of Austin FC for the team's historic first match.

Austin Police Department
UPDATE: Loop 360 closed in both directions in Northwest Austin due to a shooting incident

Residents who live in the Arboretum area in Northwest Austin are advised to shelter in place.

Early voting for the May 1 election opens April 19 at a 7 a.m. (Jack Flagler/Community Impact Newspaper)
Early voting in Austin opens April 19: See what’s on the ballot, where to vote

City residents will be making decisions on eight propositions ranging from whether to adopt a strong mayor government system to whether to reinstate public camping bans.